These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1940573

  • 1. Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
    Takahashi I, Kato K, Sugiura I, Takamatsu J, Kamiya T, Saito H.
    J Lab Clin Med; 1991 Oct; 118(4):317-25. PubMed ID: 1940573
    [Abstract] [Full Text] [Related]

  • 2. An enzyme immunoassay (ELISA) for the quantitation of human factor VII.
    Boyer C, Wolf M, Rothschild C, Migaud M, Amiral J, Mannucci PM, Meyer D, Larrieu MJ.
    Thromb Haemost; 1986 Dec 15; 56(3):250-5. PubMed ID: 2436328
    [Abstract] [Full Text] [Related]

  • 3. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen.
    Lwaleed BA, Greenfield RS, Hicks J, Birch BR, Cooper AJ.
    J Androl; 2005 Dec 15; 26(1):146-52. PubMed ID: 15611579
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
    Ohkura N, Soe G, Kohno I, Kumeda K, Wada H, Kamikubo Y, Shiku H, Kato H.
    Blood Coagul Fibrinolysis; 1999 Sep 15; 10(6):309-19. PubMed ID: 10493212
    [Abstract] [Full Text] [Related]

  • 5. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
    Suggett S, Kirchhofer D, Hass P, Lipari T, Moran P, Nagel M, Judice K, Schroeder K, Tom J, Lowman H, Adams C, Eaton D, Devaux B.
    Blood Coagul Fibrinolysis; 2000 Jan 15; 11(1):27-42. PubMed ID: 10691097
    [Abstract] [Full Text] [Related]

  • 6. A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate.
    Goudemand J, Peynet J, Chambost H, Négrier C, Briquel ME, Claeyssens S, Derlon-Borel A, Guérois C, Caron C, Scherrmann JM, Debray M, Bridey F.
    Thromb Haemost; 1998 Dec 15; 80(6):919-24. PubMed ID: 9869161
    [Abstract] [Full Text] [Related]

  • 7. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH, Duckert F.
    Thromb Haemost; 1984 Oct 31; 52(2):112-6. PubMed ID: 6395434
    [Abstract] [Full Text] [Related]

  • 8. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
    Osterud B, Miller-Andersson M, Abildgaard U, Prydz H.
    Thromb Haemost; 1976 Apr 30; 35(2):295-304. PubMed ID: 61631
    [Abstract] [Full Text] [Related]

  • 9. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.
    Bray GL, Weinmann AF, Thompson AR.
    J Lab Clin Med; 1986 Mar 30; 107(3):269-78. PubMed ID: 3485164
    [Abstract] [Full Text] [Related]

  • 10. [Activated coagulation factors in various thrombotic diseases].
    Komiyama Y, Murakami T, Masuda M, Egawa H, Takahashi H.
    Rinsho Byori; 1995 Dec 30; 43(12):1195-200. PubMed ID: 8569028
    [Abstract] [Full Text] [Related]

  • 11. Development of a radioimmunoassay for quantitating prethrombin 2 in human plasma.
    Conway EM, Lau HK, Bauer KA, Rosenberg RD.
    J Lab Clin Med; 1987 Nov 30; 110(5):567-75. PubMed ID: 3668358
    [Abstract] [Full Text] [Related]

  • 12. Determination of human thrombin-antithrombin III complex by enzyme immunoassay.
    Heimburger N, Pelzer H.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Nov 30; 115(3):269-73. PubMed ID: 2465214
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Factor IX of the blood coagulation system: a review.
    Taran LD.
    Biochemistry (Mosc); 1997 Jul 30; 62(7):685-93. PubMed ID: 9331959
    [Abstract] [Full Text] [Related]

  • 15. [Plasma level of activated factor IX-antithrombin III complex in hypercoagulable state].
    Sugiura I, Takahashi I, Kagami K, Takamatsu J.
    Rinsho Byori; 1990 Jul 30; Suppl 86():149-57. PubMed ID: 2232236
    [No Abstract] [Full Text] [Related]

  • 16. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM, Ram IE, Alderkamp GH, Bertina RM.
    Thromb Haemost; 1982 Aug 24; 48(1):54-8. PubMed ID: 6982540
    [Abstract] [Full Text] [Related]

  • 17. Activation of factor IX by factor XIa--a spectrophotometric assay for factor IX in human plasma.
    Tans G, Janssen-Claessen T, van Dieijen G, Hemker HC, Rosing J.
    Thromb Haemost; 1982 Oct 29; 48(2):127-32. PubMed ID: 6983739
    [Abstract] [Full Text] [Related]

  • 18. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.
    Pelzer H, Schwarz A, Heimburger N.
    Thromb Haemost; 1988 Feb 25; 59(1):101-6. PubMed ID: 3363526
    [Abstract] [Full Text] [Related]

  • 19. Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay.
    Saito H, Goldsmith GH.
    Blood; 1977 Sep 25; 50(3):377-85. PubMed ID: 884316
    [Abstract] [Full Text] [Related]

  • 20. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH, Bouma BN, Schalekamp MA.
    J Lab Clin Med; 1984 Apr 25; 103(4):560-73. PubMed ID: 6366096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.